Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,045 USD | +0.85% |
|
+4.36% | +19.02% |
11:58am | Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma | MT |
06-17 | Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.02% | 113B | |
+16.42% | 122B | |
+2.88% | 22.66B | |
-16.20% | 21.34B | |
-39.57% | 16.92B | |
-11.63% | 16.68B | |
-16.31% | 16.61B | |
+2.68% | 13.62B | |
+21.16% | 11.04B | |
+108.78% | 10.43B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron, Sanofi Gain FDA Approval for Kevzara to Treat Juvenile Idiopathic Arthritis